Your browser doesn't support javascript.
loading
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.
Lorenzetti, Valentina; Hindocha, Chandni; Petrilli, Kat; Griffiths, Paul; Brown, Jamie; Castillo-Carniglia, Álvaro; Caulkins, Jonathan P; Englund, Amir; ElSohly, Mahmoud A; Gage, Suzanne H; Groshkova, Teodora; Gual, Antoni; Hammond, David; Lawn, Will; López-Pelayo, Hugo; Manthey, Jakob; Mokrysz, Claire; Pacula, Rosalie Liccardo; van Laar, Margriet; Vandrey, Ryan; Wadsworth, Elle; Winstock, Adam; Hall, Wayne; Curran, H Valerie; Freeman, Tom P.
Afiliação
  • Lorenzetti V; Neuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health Sciences, Australian Catholic University, Melbourne, Australia.
  • Hindocha C; Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
  • Petrilli K; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
  • Griffiths P; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
  • Brown J; Behavioural Science and Health Institute of Epidemiology and Health, University College London, London, UK.
  • Castillo-Carniglia Á; Society and Health Research Center and School of Public Health, Universidad Mayor, Santiago, Chile.
  • Caulkins JP; Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
  • Englund A; Carnegie Mellon University Heinz College, Pittsburgh, PA, USA.
  • ElSohly MA; Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK.
  • Gage SH; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Groshkova T; National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA.
  • Gual A; Department Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi, University, MS, USA.
  • Hammond D; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Lawn W; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
  • López-Pelayo H; Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, RTA, Barcelona, Spain.
  • Manthey J; School of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.
  • Mokrysz C; Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
  • Pacula RL; Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK.
  • van Laar M; Psychiatry Department, Neurosciences Institute, Hospital Clínic, IDIBAPS, RTA, Barcelona, Spain.
  • Vandrey R; Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Wadsworth E; Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
  • Winstock A; Clinical Psychopharmacology Unit (CPU), University College London, London, UK.
  • Hall W; USC Sol Price School of Public Policy, USC Leonard D. Schaeffer Center for Health Policy & Economics, Los Angeles, CA, USA.
  • Curran HV; Trimbos Institute, Utrecht, The Netherlands.
  • Freeman TP; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Addiction ; 117(6): 1510-1517, 2022 06.
Article em En | MEDLINE | ID: mdl-34590359
BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METHODS: A group of 25 international expert cannabis researchers convened to discuss a multidisciplinary framework for minimum standards to measure cannabis use globally in diverse settings. RESULTS: The expert-based consensus agreed upon a three-layered hierarchical framework. Each layer-universal measures, detailed self-report and biological measures-reflected different research priorities and minimum standards, costs and ease of implementation. Additional work is needed to develop valid and precise assessments. CONCLUSIONS: Consistent use of the proposed framework across research, public health, clinical practice and medical settings would facilitate harmonisation of international evidence on cannabis consumption, related harms and approaches to their mitigation.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis Tipo de estudo: Guideline / Health_economic_evaluation Limite: Humans Idioma: En Revista: Addiction Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cannabis Tipo de estudo: Guideline / Health_economic_evaluation Limite: Humans Idioma: En Revista: Addiction Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália